NINE GIRLS ASK FOR A CURE FOR OVARIAN CANCER (EIN 263637035) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2008

Legal Domicile

Principal Officer

JOAN WYLLIE

Phone

6197087891

Tax Period

2025-01-01 to 2025-12-31

NINE GIRLS ASK FOR A CURE FOR OVARIAN CANCER, founded in 2008, is a micro nonprofit in the Diseases & Disorders sector that reported $3K in total revenue in fiscal year 2025. Revenue fell 47% from the prior year — a significant decline worth monitoring. Expenses of $43K exceeded revenue, resulting in a 1520% operating deficit.

Mission

TO RAISE FUNDS FOR RESEARCH AND TO RAISE AWARENESS FOR OVARIAN CANCER.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $2,650

Program Service Revenue $0

Investment Income $0

Other Revenue $0

TOTAL REVENUE $2,650

Expense Breakdown

Grants Paid $29,675

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $42,924

Other Expenses $13,249

TOTAL EXPENSES $42,924

Year-over-Year Comparison

	2025	2024	Change
Revenue	$2,650	$4,976	-0.5%
Expenses	$42,924	$19,851	+1.2%
Net Income	$-40,274	$-14,875	+1.7%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
ANGELA WEST	DIRECTOR	2.00	Director	$0	$0	$0
JEANINE KESTLER	DIRECTOR	8.00	Director	$0	$0	$0
DEBRA AUGUSTINE	DIRECTOR	2.00	Director	$0	$0	$0
KIMBERLY GROSS	DIRECTOR	2.00	Director	$0	$0	$0
JOAN WYLLIE	CEO AND DIRECTOR	12.00	Officer	$0	$0	$0
MYLLISSA MCCANN	PRESIDENT AND DIRECTOR	12.00	Officer	$0	$0	$0
MARIE ISAAKS	SECRETARY AND DIRECTOR	8.00	Officer	$0	$0	$0
CLAUDIA WYLLIE	TREASURER AND DIRECTOR	8.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$2,650	$42,924	$524,563	$-40,274
2024	$4,976	$19,851	$564,837	$-14,875
2023	$9,129	$44,162	$579,712	$-35,033
2022	$147,938	$15,223	$614,745	$132,715
2021	$76,526	$92,197	$482,030	$-15,671
2020	$34,579	$95,783	$497,701	$-61,204
2019	$42,880	$75,379	$558,905	$-32,499
2018	$111,781	$28,434	$591,404	$83,347

NINE GIRLS ASK FOR A CURE FOR OVARIAN CANCER